Sale!

Replica: EGFRm NSCLC Targeted Osimertinib 3rd Gen Therapy

Original price was: $668.00.Current price is: $509.00.

Osimertinib, Targeted therapy for EGFR mutated NSCLC, 3rd generation irreversible EGFR-TKI, CNS metastasis activity, Ex19Del or L858R mutations, EGFRm NSCLC,

SKU: SKU67EGBVUMW Category:
Guaranteed Safe Checkout

Osimertinib, Targeted therapy for EGFR mutated NSCLC, 3rd generation irreversible EGFR-TKI, CNS metastasis activity, Ex19Del or L858R mutations, EGFRm NSCLC,

Reviews

There are no reviews yet.

Be the first to review “Replica: EGFRm NSCLC Targeted Osimertinib 3rd Gen Therapy”

Your email address will not be published. Required fields are marked *

Scroll to Top